Advanced search
Publication Cover
Acta Cardiologica Volume 59, 2004 - Issue 3
Submit an article Journal homepage
3
Views
0
CrossRef citations to date
0
Altmetric
Articles

Diffuse intra-alveolar haemorrhage as a complication of thrombolytic therapy in acute myocardial infarction

Ibrahim BaranUludag University School of Medicine, Department of Cardiology, Bursa, Turkey.
,
Bülent ÖzdemirUludag University School of Medicine, Department of Cardiology, Bursa, Turkey.Correspondence[email protected]
&
≤enol Co≤kunUludag University School of Medicine, Department of Cardiology, Bursa, Turkey.
Pages 347-350 | Published online: 23 May 2017

References

  • Sane DC, Calif RM, Topol EJ, Stump DC, Mark DB, Greenberg CS. Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management. Ann Intern Med 1989; 111: 1010–22.
  • Calif RM, Topol EJ, George BS, Boswick JM, Abbott-smith C, Sigmon KN, Candela R, Masek R, Kereiakes D, O’Neill WW, Stalk RS, Stump D. Hemorrhagic complica-tions associated with the use of intravenous tissue plas-minogen activator in treatment of acute myocardial infarc-tion. Am J Med 1988; 85: 353–9.
  • Disler L, Rosendorff A. Pulmonary hemorrhage following intravenous streptokinase for acute myocardial infarction. Int J Cardiol 1990; 29: 387–90.
  • Nathan PE, Torre AV, Smith AJ, Gagliardi AJ, Rapeport KB. Spontaneus pulmonary hemorrhage following coronary trom-bolysis. Chest 1992; 101: 1150–2.
  • Cuellar OE, Torrado GE, Alvarez BM, Ferriz J, Vera AA, Garcia JJ. A diffuse pulmonary hemorrhage following thrombolytic therapy in acute myocardial infarction. Rev Esp Cardiol 1992; 45: 421–4 (in Spanish).
  • Awadh N, Ronco JJ, Bernstein V, Gilks B, Wilcox P. Spon-taneous pulmonary hemorrhage after thrombolytic therapy for acute myocardial infarction. Chest 1994; 105: 1622–4.
  • Gopalakrishnan D, Tioran T, Emanuel C, Clark VL. Diffuse pulmonary hemorrhage complicating thrombolytic therapy for acute myocardial infarction. Clin Cardiol 1997; 20: 298–300.
  • Hammoudeh AJ, Haft JI, Eichman GT. Hemoptysis and unilateral intra-alveolar hemorrhage complicating intra-venous thrombolysis for myocardial infarction. Clin Cardiol 1996; 19: 595–6.
  • Swanson GA, Kaeley G, Geraci SA: Diffuse pulmonary hemorrhage after streptokinase administration for acute myocardial infarction. Pharmacotherapy 1997; 17(2): 390–4.
  • Masip J, Vecilla F, Paez J. Diffuse pulmonary hemorrhage after fibrinolytic therapy for acute myocardial infarction. Int J Cardiol 1998; 63(1): 95–7.
  • Levine MN, Goldhaher SZ, Califf RM, Gore J, Hirsh J. Hemorrhagic complications of thrombolytic therapy in the myocardial infarction and venous thromboembolism. Chest 1992; 102: 364S–73S.
  • Chang YC, Patz EF, Goodman PC, Granger CB. Signifi-cance of hemoptysis following thrombolytic therapy for acute myocardial infarction. Chest 1996; 109: 727–9.
  • Le SP, Chatterjee K, Wolfe CL. Adult respiratory distress fol-lowing APSAC for acute myocardial infarction. Am Heart J 1992; 123: 1368–9.
  • The GUSTO investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673–82.
  • Albelda SM, Gefter WB, Epstein DM, Miller WT. Diffuse pulmonary hemorrhage: a review and classification. Radiol-ogy 1985; 154: 289–97.
  • McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolu-tion CT/bronchoscopic correlation. Chest 1994; 105: 1155–62.
  • Haponik EF, Britt EJ, Smith PL, Bleecker ER. Computed chest tomography in the evaluation of hemoptysis: impact on diagnosis and treatment. Chest 1987; 91: 80–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.